Aurora Cannabis, Inc. (NYSE: ACB) on Thursday reported a loss for the second quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period.
The Canada-based medical marijuana company said its loss from continuing operations narrowed to C$292.8 million in the December quarter from C$1.30 billion in the second quarter of 2020. The improvement reflects a 23% year-over-year increase in revenues to C$67.67 million.
Shares of Aurora Cannabis declined soon after the earnings release on Thursday evening at the New York Stock Exchange, after closing the session down 23%.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
The business world is still struggling to come out of the virus-induced slowdown, but it seems almost every retail segment benefited from the pandemic at some point. The vaccination drive
General Mills (GIS): Three factors that are expected to help drive growth for the food company going forward
Shares of General Mills Inc. (NYSE: GIS) were up 3.2% on Wednesday after the company delivered better-than-expected results for the first quarter of 2022. Net sales rose 4% year-over-year to
It is estimated that the alternative investments industry has expanded at a compound annual rate of 10.2% over the past ten years and had $11 trillion in assets under management